McEwen
MUX
17.08
-1.02
-5.64%
McEwen
US · MUX
#3215 by market cap
17.08
-1.02
-5.64%
Live - 5344 symbols - heartbeat 287s ago
· 2026-10-08 09:04
Pre-market
16.89
-1.12%
After-hours
17.08
0.00%
Overnight
17.08
0.00%
- Market cap
- 1.05B
- P/E (TTM)i
- 13.56
- P/Bi
- 1.48
- EPSi
- 0.59
- Div yieldi
- 0.00%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on MUX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.37, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.23% YoY
Margins
- Gross margin
- 24.08%
- Operating margin
- -6.54%
- Net margin
- 17.43%
Key ratios & quality
- Enterprise valuei
- 1.11B
- Altman Z-Scorei
- 0.37
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 128.18M | 117.02M | 104.79M | 136.54M | 110.42M | 166.23M | 174.48M | 197.55M |
| Gross profit | 32.08M | 8.99M | -26.95M | -6.48M | -544.00K | 17.78M | 30.94M | 47.56M |
| Selling & admin expenses | 11.13M | 12.79M | 9.20M | 11.44M | 11.89M | 15.45M | 17.17M | 26.70M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -35.32M | -55.16M | -61.43M | -53.21M | -98.21M | -104.30M | -12.62M | -12.93M |
| Pretax profit | -47.64M | -63.59M | -153.72M | -64.20M | -80.29M | 67.04M | -46.74M | 6.95M |
| Tax | -2.77M | -3.84M | -1.39M | -7.32M | 5.81M | 33.86M | -3.05M | -27.49M |
| Net profit | -44.87M | -59.75M | -152.33M | -56.88M | -86.09M | 33.18M | -43.69M | 34.43M |
| Basic EPS | -1 | -2 | -4 | -1 | -2 | 1 | -1 | 1 |
| Diluted EPS | -1.30 | -1.70 | -3.78 | -1.25 | -1.71 | 1.16 | -0.86 | 0.59 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 35.70M | 46.70M | 50.53M | 64.62M | 74.05M | 59.23M |
| Gross profit | 10.07M | 12.28M | 7.82M | 17.40M | 31.50M | 20.08M |
| Selling & admin expenses | 3.37M | 5.04M | 6.07M | 12.21M | 9.46M | 7.87M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 428.00K | 17.00K | -7.63M | -5.74M | 10.90M | -3.45M |
| Pretax profit | -7.35M | 1.93M | -1.73M | 14.10M | 33.21M | 5.79M |
| Tax | -1.08M | -1.11M | -1.27M | -24.03M | -174.00K | -3.82M |
| Net profit | -6.27M | 3.04M | -462.00K | 38.13M | 33.38M | 9.61M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 0 |
| Diluted EPS | -0.12 | 0.06 | -0.01 | 0.71 | 0.47 | 0.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 59.38M | 91.98M | 53.50M | 85.03M | 81.65M | 52.66M | 41.19M | 107.89M |
| Cash & ST investments | 18.89M | 48.34M | 20.84M | 55.93M | 40.92M | 24.76M | 14.90M | 69.78M |
| Inventory | 22.04M | 38.38M | 26.96M | 15.79M | 31.74M | 19.94M | 18.11M | 26.84M |
| Total assets | 616.94M | 631.22M | 499.94M | 525.34M | 528.72M | 657.24M | 664.62M | 820.22M |
| Total current liabilities | 36.01M | 48.80M | 45.55M | 52.40M | 84.19M | 30.00M | 47.69M | 63.81M |
| Short-term debt | 1.51M | 12.12M | 2.44M | 2.90M | 11.22M | 978.00K | 788.00K | 926.00K |
| Long-term debt | 49.21M | 39.52M | 48.16M | 48.87M | 53.98M | 40.00M | 40.00M | 126.17M |
| Total liabilities | 130,995,000.00 | 131,744,000.00 | 134,608,000.00 | 135,400,000.00 | 172,445,000.00 | 154,819,000.00 | 169,648,000.00 | 273,981,000.00 |
| Total equity | 485.95M | 499.48M | 365.33M | 389.94M | 356.27M | 502.42M | 494.98M | 546.24M |
| Retained earnings | -971.48M | -1.03B | -1.18B | -1.24B | -1.32B | -1.27B | -1.31B | -1.28B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 106.40M | 107.67M | 119.37M | 107.89M | 109.82M | 129.74M |
| Cash & ST investments | 78.21M | 67.44M | 71.90M | 69.78M | 66.03M | 87.52M |
| Inventory | 20.74M | 24.13M | 29.51M | 26.84M | 31.36M | 27.18M |
| Total assets | 730.60M | 735.62M | 747.64M | 820.22M | 972.60M | 992.11M |
| Total current liabilities | 45.26M | 45.85M | 56.77M | 63.81M | 96.67M | 63.69M |
| Short-term debt | 766.00K | 727.00K | 833.00K | 926.00K | 3.82M | 6.83M |
| Long-term debt | 125.53M | 125.77M | 125.97M | 126.17M | 123.37M | 120.57M |
| Total liabilities | 250,760,000.00 | 251,143,000.00 | 259,080,000.00 | 273,981,000.00 | 320,637,000.00 | 285,470,000.00 |
| Total equity | 479.84M | 484.48M | 488.56M | 546.24M | 651.96M | 706.64M |
| Retained earnings | -1.32B | -1.31B | -1.31B | -1.28B | -1.24B | -1.23B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 487.00K | -39.53M | -27.87M | -20.06M | -56.58M | -39.64M | 29.45M | 6.87M |
| Depreciation & amortization | 16.43M | 25.54M | 23.09M | 25.34M | 19.53M | 30.36M | 30.86M | 27.85M |
| Free cash flow | -80.83M | -69.23M | -41.25M | -54.95M | -80.77M | -65.74M | -13.64M | -37.77M |
| Dividends paid | -3.37M | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 15.01M | 71.32M | 19.64M | 11.97M | 14.38M | 13.43M | 20.42M | 4.87M |
| Ending cash balance | 30.49M | 46.50M | 24.44M | 60.63M | 43.58M | 27.51M | 17.46M | 55.26M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.93M | 478.00K | 5.22M | 3.10M | 12.10M | 46.22M |
| Depreciation & amortization | 6.17M | 6.85M | 7.64M | 7.18M | 7.08M | 8.19M |
| Free cash flow | -16.47M | -9.17M | -5.61M | -6.52M | -2.45M | 20.92M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 0 | 4.87M | 14.83M | 0 |
| Ending cash balance | 72.46M | 57.55M | 55.25M | 55.26M | 60.91M | 83.52M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -8.91 | -12.13 | -35.23 | -15.32 | -23.23 | 13.40 | -8.76 | 6.61 |
| ROA %i | -7.42 | -9.57 | -26.93 | -11.06 | -15.38 | 9.33 | -6.61 | 4.64 |
| ROIC %i | -8.44 | -10.89 | -29.73 | -12.09 | -18.33 | 5.60 | -8.08 | 5.68 |
| 5-year avg ROE %i | -12.70 | -4.62 | -10.72 | -14.76 | -18.96 | -14.50 | -13.83 | -5.46 |
| EBIT margin %i | -26.92 | -47.14 | -139.60 | -42.48 | -65.66 | -62.75 | -7.23 | -6.54 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.65 | 1.88 | 1.17 | 1.62 | 0.97 | 1.76 | 0.86 | 1.69 |
| Quick ratioi | 0.58 | 1.10 | 0.50 | 1.14 | 0.52 | 0.99 | 0.40 | 1.19 |
| Debt / assetsi | 9.02 | 8.97 | 10.73 | 10.14 | 12.56 | 6.31 | 6.34 | 15.63 |
| LT debt / equityi | 11.14 | 8.92 | 14.02 | 13.43 | 17.09 | 8.06 | 8.35 | 23.30 |
| Interest coveragei | -- | -- | -19.68 | -9.35 | -9.31 | -- | -- | -- |
| Revenue CAGR (3Y) %i | 20.66 | 24.67 | 15.81 | 2.13 | -1.92 | 16.63 | 8.52 | 21.40 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -6.15 | -2.79 | -2.41 | 6.61 | 13.09 | 13.54 |
| ROA %i | -4.32 | -1.96 | -1.68 | 4.64 | 8.70 | 9.34 |
| ROIC %i | -5.23 | -2.38 | -2.05 | 5.68 | 10.68 | 11.15 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -4.11 | -3.03 | -9.44 | -6.54 | -1.04 | 12.84 |
| FCF / sales %i | -- | -- | -- | -- | -- | 2.55 |
| Current ratioi | 2.35 | 2.35 | 2.10 | 1.69 | 1.14 | 2.04 |
| Quick ratioi | 1.78 | 1.69 | 1.45 | 1.19 | 0.74 | 1.48 |
| Debt / assetsi | 17.45 | 17.35 | 17.08 | 15.63 | 13.17 | 12.94 |
| LT debt / equityi | 26.41 | 26.19 | 25.97 | 23.30 | 19.07 | 17.20 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Fox Complex is the largest reported line at 48.73% of revenue, across 3 reported segments.
- Gold Bar Mine Complex follows at 43.92%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Fox Complex48.73%
Gold Bar Mine Complex43.92%
El Gallo7.35%
Quote time 2026-10-08 09:04:53 · For reference only, not investment advice and not tailored to your situation.